Caxton Associates (New York)’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,528
| Closed | -$346K | – | 557 |
|
|
2021
Q4 | $346K | Buy |
+6,528
| New | +$346K | 0.04% | 347 |
|
|
2020
Q2 | – | Sell |
-2,047
| Closed | -$204K | – | 518 |
|
|
2020
Q1 | $204K | Buy |
+2,047
| New | +$204K | 0.04% | 342 |
|
|
2019
Q3 | – | Sell |
-2,467
| Closed | -$297K | – | 446 |
|
|
2019
Q2 | $297K | Buy |
+2,467
| New | +$297K | 0.04% | 272 |
|
|
2018
Q4 | – | Sell |
-2,710
| Closed | -$311K | – | 343 |
|
|
2018
Q3 | $311K | Buy |
+2,710
| New | +$311K | 0.02% | 273 |
|